Search - Centre Oscar Lambret Access content directly

Filter your results

104 Results
Deposit type : Fulltext
Image document

Quelle démarche d’éducation thérapeutique (ETP) pour les adolescents et jeunes adultes atteints de cancer ? Expérience du groupe ETP de « Go-AJA »

Nadège Corradini , Loïc Dagorne , Marielle Retailleau , Françoise Redini , Hélène Sudour-Bonnange et al.
Bulletin du Cancer, 2016, 103 (12), pp.966 - 978. ⟨10.1016/j.bulcan.2016.10.006⟩
Journal articles inserm-01701134v1
Image document

Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature

Marie Dworczak , Marie-Cécile Le Deley , Antoine Adenis , Guillaume Piessen , Éric Lartigau et al.
Bulletin du Cancer, 2020, 107, pp.982 - 990. ⟨10.1016/j.bulcan.2020.07.001⟩
Journal articles hal-03493168v1
Image document

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials

Derek Dinart , Julien Fraisse , Diego Tosi , Audrey Mauguen , Célia Touraine et al.
BMC Medical Informatics and Decision Making, 2020, 20 (1), ⟨10.1186/s12911-020-01149-3⟩
Journal articles hal-02889984v1
Image document

Emotional distress and subjective impact of the disease in young women with breast cancer and their spouses

Christelle Duprez , Laurence Vanlemmens , Aurélie Untas , Pascal Antoine , Anne Lesur et al.
Future Oncology, 2017, 13 (29), pp.2667-2680. ⟨10.2217/fon-2017-0264⟩
Journal articles hal-02457803v2
Image document

Embryonal tumors with multilayered rosettes in children: the SFCE experience

Meryl Horwitz , Christelle Dufour , Pierre Leblond , Franck Bourdeaut , Cécile Faure-Conter et al.
Child's Nervous System, 2016, 32 (2), pp.299-305. ⟨10.1007/s00381-015-2920-2⟩
Journal articles hal-01368643v1
Image document

A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome

Pauline Rochefort , Antoine Italiano , Valérie Laurence , Nicolas Penel , Audrey Lardy-Cleaud et al.
Scientific Reports, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩
Journal articles hal-02613645v1
Image document

CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database

P. Gougis , M. Carton , C. Tchokothe , M. Campone , F. Dalenc et al.
The Breast, 2020, 49, pp.17-24. ⟨10.1016/j.breast.2019.10.004⟩
Journal articles hal-02888468v1
Image document

Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort

Sophie Frank , Matthieu Carton , Coraline Dubot , Mario Campone , Barbara Pistilli et al.
Breast, 2020, 52, pp.50-57. ⟨10.1016/j.breast.2020.04.009⟩
Journal articles hal-02888009v2
Image document

Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Emmanuelle Samalin , Christelle de La Fouchardière , Simon Thèzenas , Valérie Boige , Hélène Senellart et al.
Clinical Colorectal Cancer, 2020, ⟨10.1016/j.clcc.2020.04.008⟩
Journal articles hal-02912931v1
Image document

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

Antoine Adenis , J. Bennouna , P.L. Etienne , E. Bogart , E. Francois et al.
European Journal of Cancer, 2019, 111, pp.12-20. ⟨10.1016/j.ejca.2019.01.016⟩
Journal articles hal-02418932v1
Image document

Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis

Vincent Berry , Laurent Basson , Emilie Bogart , Olivier Mir , Jean-Yves Blay et al.
Cancer, 2017, Cancer, 123, pp.2294-2302. ⟨10.1002/cncr.30661⟩
Journal articles hal-02638646v1
Image document

Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial

Gilles Houvenaeghel , Monique Cohen , Pédro Raro , Jérémy de Troyer , Pierre Gimbergues et al.
npj Breast Cancer, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
Journal articles hal-03406273v1
Image document

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

A. Le Cesne , P. Marec-Berard , J.-Y. Blay , N. Gaspar , F. Bertucci et al.
European Journal of Cancer, 2019, 119, pp.151-157. ⟨10.1016/j.ejca.2019.07.018⟩
Journal articles hal-02529696v1
Image document

Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial

Stefano Kim , Bruno Buecher , Thierry André , Marine Jary , François-Clément Bidard et al.
BMC Cancer, 2020, 20 (1), pp.352. ⟨10.1186/s12885-020-06841-1⟩
Journal articles hal-03130294v1
Image document

Assessing prognostic and predictive biomarkers of regorafenib response in patients with advanced soft tissue sarcoma: REGOSARC study

Thomas Brodowicz , Bernadette Liegl-Atzwanger , Nicolas Penel , Olivier Mir , Jean Yves Blay et al.
Cancers, 2020, 12 (12), pp.1-12. ⟨10.3390/cancers12123746⟩
Journal articles hal-03109189v1
Image document

Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR

Nicolas Macagno , Frédéric Fina , Nicolas Penel , Corinne Bouvier , Isabelle Nanni et al.
Oncotarget, 2018, 9 (26), pp.18296-18308. ⟨10.18632/oncotarget.24817⟩
Journal articles hal-01794155v1
Image document

Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study

Caroline Brard , Lisa V Hampson , Nathalie Gaspar , Marie-Cécile Le Deley , Gwénaël Le Teuff et al.
BMC Medical Research Methodology, 2019, 19 (1), pp.85. ⟨10.1186/s12874-019-0714-z⟩
Journal articles inserm-02308658v1
Image document

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1 Diagnostic exploration and staging, surgery, perioperative care, and pathology

V Lavoue , C Huchon , C Akladios , P Alfonsi , N Bakrin et al.
Journal of Gynecology Obstetrics and Human Reproduction, 2019, 48 (6), pp.369-378. ⟨10.1016/j.jogoh.2019.03.017⟩
Journal articles hal-02121102v1
Image document

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

Christophe Mariette , Florence Renaud , Guillaume Piessen , Patrick Gele , Marie-Christine Copin et al.
BMC Cancer, 2018, 18 (1), pp.139. ⟨10.1186/s12885-018-3991-8⟩
Journal articles hal-02283073v1
Image document

Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy

Sheraz Markar , Caroline Gronnier , Arnaud Pasquer , Alain Duhamel , Hélène Behal et al.
Annals of Surgical Oncology, 2017, 24 (13), pp.3911-3920. ⟨10.1245/s10434-017-6088-8⟩
Journal articles hal-01892109v1
Image document

Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study

Amandine Garcia , Monique Buisson , Francesca Damiola , Chloé Tessereau , Laure Barjhoux et al.
European Journal of Human Genetics, 2016, 24 (9), pp.1324-1329. ⟨10.1038/ejhg.2015.284⟩
Journal articles inserm-01994617v1
Image document

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Celine Lefebvre , Thomas Bachelot , Thomas Filleron , Marion Pedrero , Mario Campone et al.
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
Journal articles hal-02297451v1
Image document

Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique

J.M. Hannoun-Lévi , M.-È. Chand , P. Blanchard , C. Chargari , A. Escande et al.
Cancer/Radiothérapie, 2020, 24, pp.876 - 881. ⟨10.1016/j.canrad.2020.03.010⟩
Journal articles hal-03493632v1
Image document

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

Fabien Vidal , Paul Guerby , Mathieu Luyckx , Pascale Haddad , Eberhard Stoeckle et al.
PLoS ONE, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩
Journal articles inserm-02940269v1
Image document

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model

Gilles Houvenaeghel , Eric Lambaudie , Jean-Marc Classe , Chafika Mazouni , Sylvia Giard et al.
BMC Cancer, 2019, 19 (1), pp.45. ⟨10.1186/s12885-018-5227-3⟩
Journal articles hal-01983749v1
Image document

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

Emmanuelle Bompas , Loïc Campion , Antoine Italiano , Axel Le Cesne , Christine Chevreau et al.
Cancer Medicine, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩
Journal articles hal-01978221v1
Image document

MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma

Nicolas Giraud , Olivier Saut , Thomas Aparicio , Philippe Ronchin , Louis-Arnaud Bazire et al.
Cancers, 2021, 13 (2), pp.193. ⟨10.3390/cancers13020193⟩
Journal articles hal-03428535v1
Image document

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care

Antonio Di Meglio , Julie Havas , Davide Soldato , Daniele Presti , Elise Martin et al.
Journal of Clinical Oncology, 2022, 40 (10), pp.1111--1123. ⟨10.1200/JCO.21.01252⟩
Journal articles hal-03855945v1
Image document

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification

Michele Boisdron-Celle , Jean Philippe Metges , Olivier Capitain , Antoine Adenis , Jean Luc Raoul et al.
Seminars in Oncology, 2017, 44 (1), pp.24 - 33. ⟨10.1053/j.seminoncol.2017.02.007⟩
Journal articles inserm-01819425v1
Image document

How to report toxicity associated with targeted therapies?

B. Cabarrou , J. M Boher , E. Bogart , E. Tresch-Bruneel , N. Penel et al.
Annals of Oncology, 2016, 27 (8), pp.1633-1638. ⟨10.1093/annonc/mdw218⟩
Journal articles inserm-01987742v1